Pharmacokinetics of phenprobamate after oral administration to healthy subjects

Arzneimittel-Forschung/Drug Research

Volumn 48, Issue 11, 1998, Pages 1068-1071

  Tulunay, F Cankat ^a   Onaran, H Ongun ^a   Ergün, Hakan ^a   Ucar, Atila ^a   Usanmaz, Suzan ^a   Embil, Koral ^b   Tulunay, Melek ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Embil Pharmaceutical Company Limited   (Turkey)

Author keywords

CAS 673 31 4; Phenprobamate, clinical pharmacokinetics; Tranquilizer

Indexed keywords

CLOFIBRIC ACID; ETHER; HYDROCHLORIC ACID; PHENPROBAMATE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL PROTOCOL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; REPRODUCIBILITY;

ADOLESCENT; ADULT; AREA UNDER CURVE; CARBAMATES; FEMALE; HALF-LIFE; HUMANS; MALE; MUSCLE RELAXANTS, CENTRAL;

EID: 0031728619     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Surber, W., Wagner-Jauregg, T., Häring, M., Arzneim.-Forsch./Drug Res. 9, 143 (1959)
2. Schatz, F., Jahn, U., Arzneim.-Forsch./Drug Res. 16, 866 (1996)
3. Kuriyama, M., Okada, K., Eisei Kagaku 11, 176 (1965)
4. Sun, J. X. S., Embil, K., Lee, C. S., Pharm. Res. 5, 387 (1988)
5. Sun, J. X. S., Embil, K., Lee, C. S., Biopharm. Drug Dispos. 8, 341 (1987)
6. Walkenstein, S. S., Knebel, C. M., Macmullen, J. A. et al., J. Pharmacol. Exp. Ther. 123, 254 (1958)
7. Buhler, D. R., J. Pharmacol. Exper. Ther. 145, 232 (1964)
8. Horie, M., Baba, S., Biomed. Mass Spectrom. 6, 63 (1979)